Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Brian Koss

Concepts (141)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms, Experimental
2
2020
115
0.850
 Why?
Small Molecule Libraries
3
2019
72
0.810
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2020
62
0.750
 Why?
Lymphocytes, Tumor-Infiltrating
1
2020
74
0.730
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
2016
13
0.660
 Why?
Biomimetic Materials
1
2016
11
0.560
 Why?
Proto-Oncogene Proteins
1
2016
169
0.520
 Why?
Peptide Fragments
1
2016
242
0.510
 Why?
Cell Lineage
2
2014
93
0.490
 Why?
Melanoma
3
2023
313
0.470
 Why?
Fusion Proteins, bcr-abl
1
2013
23
0.470
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2013
105
0.410
 Why?
Mice
13
2023
6428
0.380
 Why?
Cell Line, Tumor
6
2020
1551
0.350
 Why?
Apoptosis
8
2023
1302
0.340
 Why?
Proto-Oncogene Proteins c-bcl-2
4
2014
158
0.320
 Why?
Histones
2
2020
335
0.300
 Why?
Antineoplastic Agents
3
2023
1300
0.290
 Why?
Animals
13
2023
14409
0.270
 Why?
Tumor Microenvironment
3
2023
210
0.260
 Why?
Antigen Presentation
1
2023
28
0.240
 Why?
Gene Rearrangement
1
2024
76
0.230
 Why?
DNA-Activated Protein Kinase
1
2023
23
0.230
 Why?
Mice, Transgenic
2
2016
658
0.220
 Why?
Neoplasms
3
2023
1322
0.210
 Why?
Cell Survival
5
2019
657
0.210
 Why?
Mice, Inbred C57BL
4
2016
2001
0.210
 Why?
Leukemia, Myeloid, Acute
1
2024
192
0.210
 Why?
Hematologic Neoplasms
1
2023
100
0.200
 Why?
Tumor Suppressor Protein p53
1
2023
251
0.200
 Why?
Histone Code
2
2020
32
0.190
 Why?
Epigenesis, Genetic
2
2020
399
0.180
 Why?
Xenograft Model Antitumor Assays
2
2019
219
0.170
 Why?
Transcription Factors
2
2023
622
0.170
 Why?
Polycomb Repressive Complex 2
1
2019
50
0.170
 Why?
Integrin alpha Chains
1
2019
10
0.170
 Why?
Tumor Cells, Cultured
2
2019
477
0.170
 Why?
Cell Cycle Checkpoints
1
2019
35
0.170
 Why?
Cadherins
1
2019
72
0.160
 Why?
Melanoma, Experimental
1
2019
49
0.160
 Why?
Antigens, CD
1
2019
242
0.150
 Why?
CTLA-4 Antigen
1
2017
29
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2017
40
0.150
 Why?
DNA-Binding Proteins
1
2019
462
0.140
 Why?
Humans
15
2024
54391
0.130
 Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2014
1
0.130
 Why?
Transfection
1
2016
399
0.130
 Why?
Granulocytes
1
2014
27
0.130
 Why?
Drug Resistance, Neoplasm
1
2017
309
0.130
 Why?
Myeloid Cells
1
2014
38
0.130
 Why?
Protein Processing, Post-Translational
2
2020
183
0.120
 Why?
CD8-Positive T-Lymphocytes
3
2023
116
0.120
 Why?
Monocytes
1
2014
156
0.120
 Why?
Gene Expression Regulation, Leukemic
1
2013
36
0.120
 Why?
Lung Neoplasms
1
2019
643
0.110
 Why?
High-Throughput Screening Assays
1
2012
37
0.110
 Why?
B-Lymphocytes
1
2013
176
0.110
 Why?
Cells, Cultured
2
2013
1737
0.110
 Why?
Antibodies, Monoclonal
1
2017
564
0.110
 Why?
Mitochondria
2
2013
490
0.100
 Why?
Peptides
1
2012
276
0.100
 Why?
Ubiquitin
1
2010
51
0.090
 Why?
T-Lymphocytes
2
2023
374
0.080
 Why?
Disease Models, Animal
1
2013
1647
0.080
 Why?
Structure-Activity Relationship
2
2019
423
0.060
 Why?
Multiple Myeloma
1
2019
3049
0.060
 Why?
Myeloid-Lymphoid Leukemia Protein
1
2024
16
0.060
 Why?
Proto-Oncogenes
1
2024
29
0.060
 Why?
Major Histocompatibility Complex
1
2023
14
0.060
 Why?
Interferons
1
2023
44
0.060
 Why?
Proto-Oncogene Proteins c-ret
1
2024
35
0.060
 Why?
Histocompatibility Antigens Class I
1
2023
52
0.060
 Why?
Cell Proliferation
2
2019
1097
0.060
 Why?
HLA Antigens
1
2023
56
0.060
 Why?
Cell Respiration
2
2013
51
0.060
 Why?
Microscopy, Electron, Transmission
2
2013
87
0.060
 Why?
Antigens, Neoplasm
1
2023
170
0.050
 Why?
Immunotherapy, Adoptive
1
2023
134
0.050
 Why?
CD4-Positive T-Lymphocytes
1
2023
181
0.050
 Why?
Proteomics
1
2023
343
0.050
 Why?
Promoter Regions, Genetic
1
2023
520
0.050
 Why?
Workflow
1
2020
57
0.050
 Why?
Azepines
1
2019
22
0.040
 Why?
DNA
1
2023
581
0.040
 Why?
Methylation
1
2019
130
0.040
 Why?
Mice, Inbred NOD
1
2019
99
0.040
 Why?
Molecular Dynamics Simulation
1
2019
40
0.040
 Why?
Mice, SCID
1
2019
196
0.040
 Why?
Crystallography, X-Ray
1
2019
178
0.040
 Why?
Drug Evaluation, Preclinical
1
2019
158
0.040
 Why?
Protein Structure, Tertiary
1
2019
289
0.040
 Why?
Oxidative Stress
1
2024
958
0.040
 Why?
Binding Sites
1
2019
440
0.040
 Why?
Membrane Potential, Mitochondrial
1
2016
48
0.040
 Why?
Immunoprecipitation
1
2016
73
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2017
53
0.040
 Why?
bcl-X Protein
1
2016
61
0.040
 Why?
Drug Design
1
2016
133
0.030
 Why?
Drug Discovery
1
2016
90
0.030
 Why?
Proteome
1
2017
178
0.030
 Why?
Fas-Associated Death Domain Protein
1
2014
6
0.030
 Why?
Caspase 8
1
2014
16
0.030
 Why?
Minor Histocompatibility Antigens
1
2014
16
0.030
 Why?
Neoplasm Transplantation
1
2014
94
0.030
 Why?
Coculture Techniques
1
2014
159
0.030
 Why?
Immune Tolerance
1
2014
105
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2019
868
0.030
 Why?
RNA, Small Interfering
1
2014
253
0.030
 Why?
Mice, 129 Strain
1
2013
49
0.030
 Why?
bcl-2 Homologous Antagonist-Killer Protein
1
2013
22
0.030
 Why?
bcl-2-Associated X Protein
1
2013
73
0.030
 Why?
Sequence Deletion
1
2013
99
0.030
 Why?
Proton-Translocating ATPases
1
2012
12
0.030
 Why?
Oxygen Consumption
1
2013
223
0.030
 Why?
Membrane Potentials
1
2012
139
0.030
 Why?
Mice, Knockout
1
2014
927
0.030
 Why?
Cell Differentiation
1
2014
720
0.030
 Why?
Models, Molecular
1
2012
423
0.020
 Why?
Adenosine Triphosphate
1
2012
242
0.020
 Why?
Hematopoietic System
1
2010
5
0.020
 Why?
Leupeptins
1
2010
8
0.020
 Why?
Cycloheximide
1
2010
32
0.020
 Why?
Embryo, Mammalian
1
2010
69
0.020
 Why?
Myocardium
1
2013
443
0.020
 Why?
Protein Stability
1
2010
44
0.020
 Why?
Mutant Proteins
1
2010
41
0.020
 Why?
Half-Life
1
2010
92
0.020
 Why?
Child
1
2023
7368
0.020
 Why?
Ubiquitination
1
2010
47
0.020
 Why?
Ubiquitin-Protein Ligases
1
2010
100
0.020
 Why?
Alleles
1
2010
277
0.020
 Why?
Proteasome Inhibitors
1
2010
111
0.020
 Why?
Treatment Outcome
1
2020
5612
0.020
 Why?
Dose-Response Relationship, Drug
1
2012
1476
0.020
 Why?
Fibroblasts
1
2010
386
0.020
 Why?
Signal Transduction
1
2014
1752
0.020
 Why?
Heart Failure
1
2013
541
0.020
 Why?
Muscle, Skeletal
1
2013
847
0.020
 Why?
Cell Line
1
2010
1152
0.020
 Why?
Mutation
1
2010
1504
0.010
 Why?
Female
1
2019
28471
0.010
 Why?
Koss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (141) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department